CASEY ESTES: Open Payments
NPI 1831952951 · WEST VALLEY CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 51 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $835 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $252 |
| AstraZeneca Pharmaceuticals LP | 4 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $157 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| Indivior Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $33 |
| Lilly USA, LLC | 2 | $29 |
| Amgen Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
Products named: FARXIGA, Kerendia, VRAYLAR, JARDIANCE, TRELEGY ELLIPTA, UBRELVY, QULIPTA, SUBLOCADE.
Industry payments across UT — which companies pay providers there.
